CROSSJECT appoints Lionel Seltz as Chief Financial Officer

CROSSJECT appoints Lionel Seltz as Chief Financial Officer

DIJON, France – 25 mars 2026 (06.00 PM CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), the specialty pharmaceuticals company developing emergency medicines based on its proprietary ZENEO® needle-free auto-injector platform, notably ZEPIZURE® for the…

DIJON, France 25 mars 2026 (06.00 PM CET) CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), the specialty pharmaceuticals company developing emergency medicines based on its proprietary ZENEO® needl… [+2660 chars]